NantWorks | Evaluate

Therapy focus – pancreatic cancer developers press on, despite failures

August 31, 2017

Corporate venture firms – dedicated followers of fashion?

Eagerly pursuing all the latest fads and trends.

February 27, 2017

Therapy focus – against the odds, cancer vaccines plough on

October 21, 2016

Irhythm rocks the Nasdaq

September 02, 2016

Snippet roundup: Tecentriq gets lung cancer win, Enbrel biosimilar patent dance intensifies

January 19, 2016

As venture capital flows freely, Europe's haves and have nots emerge

January 18, 2016

Biotechs raise record venture capital haul in 2015

January 12, 2016

JP Morgan – Jumping in front of the cancer immunotherapy parade

October 14, 2015

Venture treasure bath for oncology, pennies for others

August 03, 2015

Interview – Alacris eager to put drug development model into practice

July 16, 2015

Ferocious venture funding pace eases slightly in Q2

Load More